222 related articles for article (PubMed ID: 35360926)
21. Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy.
Koemans EA; Voigt S; Rasing I; van Harten TW; Jolink WMT; Schreuder FHBM; van Zwet EW; van Buchem MA; van Osch MJP; Terwindt GM; Klijn CJM; van Walderveen MAA; Wermer MJH
Stroke; 2022 Feb; 53(2):552-557. PubMed ID: 34538086
[TBL] [Abstract][Full Text] [Related]
22. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
[TBL] [Abstract][Full Text] [Related]
23. Sex Differences in Onset and Progression of Cerebral Amyloid Angiopathy.
Koemans EA; Castello JP; Rasing I; Abramson JR; Voigt S; Perosa V; van Harten TW; van Zwet EW; Terwindt GM; Gurol ME; Rosand J; Greenberg SM; van Walderveen MAA; Biffi A; Viswanathan A; Wermer MJH
Stroke; 2023 Feb; 54(2):306-314. PubMed ID: 36689586
[TBL] [Abstract][Full Text] [Related]
24. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij BH; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
[TBL] [Abstract][Full Text] [Related]
25. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
[TBL] [Abstract][Full Text] [Related]
26. Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy.
Martinez-Ramirez S; van Rooden S; Charidimou A; van Opstal AM; Wermer M; Gurol ME; Terwindt G; van der Grond J; Greenberg SM; van Buchem M; Viswanathan A
Stroke; 2018 Aug; 49(8):1913-1919. PubMed ID: 30012821
[TBL] [Abstract][Full Text] [Related]
27. MRI for in vivo diagnosis of cerebral amyloid angiopathy: Tailoring artifacts to image hemorrhagic biomarkers.
Boulouis G; Edjlali-Goujon M; Moulin S; Ben Hassen W; Naggara O; Oppenheim C; Cordonnier C
Rev Neurol (Paris); 2017 Nov; 173(9):554-561. PubMed ID: 28987481
[TBL] [Abstract][Full Text] [Related]
28. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation.
Chatterjee P; Tegg M; Pedrini S; Fagan AM; Xiong C; Singh AK; Taddei K; Gardener S; Masters CL; Schofield PR; Multhaup G; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; van Buchem MA; Stoops E; Vanderstichele H; Teunissen CE; Hankey GJ; Wermer MJH; Sohrabi HR; Martins RN; The Dominantly Inherited Alzheimer Network
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805778
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
30. Mediators of cognitive impairment in cerebral amyloid angiopathy.
Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
[TBL] [Abstract][Full Text] [Related]
31. Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial.
Voigt S; Koemans EA; Rasing I; van Etten ES; Terwindt GM; Baas F; Kaushik K; van Es ACGM; van Buchem MA; van Osch MJP; van Walderveen MAA; Klijn CJM; Verbeek MM; van der Weerd L; Wermer MJH
Trials; 2023 Jun; 24(1):378. PubMed ID: 37277877
[TBL] [Abstract][Full Text] [Related]
32. Cerebral Amyloid Angiopathy with Lobar Haemorrhages and CAA-Related Inflammation in an Indian Family.
Maramattom BV
Cerebrovasc Dis Extra; 2022; 12(1):23-27. PubMed ID: 35086090
[TBL] [Abstract][Full Text] [Related]
33. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
34. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers.
Boulouis G; Charidimou A; Pasi M; Roongpiboonsopit D; Xiong L; Auriel E; van Etten ES; Martinez-Ramirez S; Ayres A; Vashkevich A; Schwab KM; Rosand J; Goldstein JN; Gurol ME; Greenberg SM; Viswanathan A
J Neurol Sci; 2017 Sep; 380():64-67. PubMed ID: 28870591
[TBL] [Abstract][Full Text] [Related]
35. Cortical Microinfarcts on 3T Magnetic Resonance Imaging in Cerebral Amyloid Angiopathy.
van den Brink H; Zwiers A; Switzer AR; Charlton A; McCreary CR; Goodyear BG; Frayne R; Biessels GJ; Smith EE
Stroke; 2018 Aug; 49(8):1899-1905. PubMed ID: 29986931
[TBL] [Abstract][Full Text] [Related]
36. Cerebral amyloid angiopathy with focal presentation-about 3 cases.
Garnier-Crussard A; Taki A; Bonnefoy M; Bar JY; Krolak-Salmon P; Cotton F; Gilbert T
Neuroradiology; 2020 Sep; 62(9):1195-1197. PubMed ID: 32415390
[TBL] [Abstract][Full Text] [Related]
37. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.
Kimberly WT; Gilson A; Rost NS; Rosand J; Viswanathan A; Smith EE; Greenberg SM
Neurology; 2009 Apr; 72(14):1230-5. PubMed ID: 19349602
[TBL] [Abstract][Full Text] [Related]
38. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.
Schultz AP; Kloet RW; Sohrabi HR; van der Weerd L; van Rooden S; Wermer MJH; Moursel LG; Yaqub M; van Berckel BNM; Chatterjee P; Gardener SL; Taddei K; Fagan AM; Benzinger TL; Morris JC; Sperling R; Johnson K; Bateman RJ; ; Gurol ME; van Buchem MA; Martins R; Chhatwal JP; Greenberg SM
Ann Neurol; 2019 Oct; 86(4):616-625. PubMed ID: 31361916
[TBL] [Abstract][Full Text] [Related]
39. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
40. Striped occipital cortex and intragyral hemorrhage: Novel magnetic resonance imaging markers for cerebral amyloid angiopathy.
Koemans EA; Voigt S; Rasing I; Jolink W; van Harten TW; van der Grond J; van Rooden S; Schreuder F; Freeze WM; van Buchem MA; van Zwet EW; van Veluw SJ; Terwindt GM; van Osch M; Klijn C; van Walderveen M; Wermer M
Int J Stroke; 2021 Dec; 16(9):1031-1038. PubMed ID: 33535905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
